Signorelli GR, Lehocki F, Mora Fernández M, et al. Connected health as an enabler of cancer patient support. J Med Internet Res. 2019;21(3):56–63. doi:https://doi.org/10.2196/14360

Article  Google Scholar 

Lu DJ, Girgis M, David JM, et al. Evaluation of mobile health applications to track patient-reported outcomes for oncology patients: a systematic review. J Radiat Oncol. 2021;34(2):120–134. doi:https://doi.org/10.1016/j.jro.2021.00129

Article  Google Scholar 

Rowland, S.P., Fitzgerald, J.E., Holme, T. et al. What is the clinical value of mHealth for patients?. npj Digit. Med. 3, 4 (2020). https://doi.org/10.1038/s41746-019-0206-x

Article  PubMed  PubMed Central  Google Scholar 

Jean-Louis G, Seixas AA. The value of decentralized clinical trials: Inclusion, accessibility, and innovation. Science. 2024;385(6711): eadq4994. doi: https://doi.org/10.1126/science.adq4994.

Article  PubMed  CAS  Google Scholar 

Thota R, Hurley PA, Miller TM, Bruinooge SS, Lipset C, Harvey RD, Black LJ, Dinsdale A, Merrill JK, Pollastro T, Prindiville SA, Rizvi MA, Sherwood S, Nowakowski GS. Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement. J Clin Oncol. 2024;42(33):3986–3995. doi: https://doi.org/10.1200/JCO.24.00961. Epub 2024 Jul 30.

Article  PubMed  Google Scholar 

Burden AM, Singh P, Natanegara F. Design and Execution of Sustainable Decentralized Clinical Trials. Clin Pharmacol Ther. 2023;114(7):400–412. doi:https://doi.org/10.1002/cpt.3009

Article  Google Scholar 

Sato T, Ishimaru H, Takata T, Sasaki H, Shikano M. Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations. Front Med (Lausanne). 2022;9:903188. doi: https://doi.org/10.3389/fmed.2022.903188.

Article  PubMed  Google Scholar 

Xia Y, Guan X, Shi Z, Luo Y, He P. Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial. BMJ Open. 2025;15(1):e093374. doi: https://doi.org/10.1136/bmjopen-2024-093374.

Article  PubMed  PubMed Central  Google Scholar 

Baethge, C., Goldbeck-Wood, S. & Mertens, S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4, 5 (2019). https://doi.org/10.1186/s41073-019-0064-8

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313–320. doi:https://doi.org/10.3322/caac.21660

Article  CAS  Google Scholar 

Harrison R, Abebe R, Kim S, et al. Accelerating cancer drug development: The role of biomarkers and companion diagnostics. J Clin Oncol. 2022;40(2):145–155. doi:https://doi.org/10.1200/JCO.21.00776

Article  Google Scholar 

Kim ES, Uhm JE, Lee JM, et al. Overcoming barriers in oncology trials: The evolving role of digital technology. Oncologist. 2024;29(3):173–180. doi:https://doi.org/10.1634/theoncologist.2024.03.10

Article  Google Scholar 

Allison K, Patel D, Kaur R. Assessing multiple factors affecting minority participation in clinical trials: Development of the clinical trials participation barriers survey. Cureus. 2022;14(5):1231–1240. doi:https://doi.org/10.7759/cureus.12345.

Article  Google Scholar 

Unger JM, Cook E, Tai E, Bleyer A. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. Am Soc Clin Oncol Educ Book. 2016;35:185–98. doi: https://doi.org/10.1200/EDBK_156686.

Article  PubMed  PubMed Central  Google Scholar 

ASPE. Examination of clinical trial costs and barriers in drug development. Available from: https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0

Smith ZP, DiMasi JA, Getz KA. New Estimates on the Cost of a Delay Day in Drug Development. Ther Innov Regul Sci. 2024;58(5):855–862. doi: https://doi.org/10.1007/s43441-024-00667-w.

Article  PubMed  Google Scholar 

Johnson O. An evidence-based approach to conducting clinical trial feasibility assessments. Clin Investig. 2015;5(5):491–499.

Article  CAS  Google Scholar 

Moseson H, Kumar S, Juusola JL. Comparison of study samples recruited with virtual versus traditional recruitment methods. Contemp Clin Trials Commun. 2020;19:100590. doi: https://doi.org/10.1016/j.conctc.2020.100590.

Article  PubMed  PubMed Central  Google Scholar 

Lee EM, Jiménez-Fonseca P, Galán-Moral R, Coca-Membribes S, Fernández-Montes A, Sorribes E, García-Torralba E, Puntí-Brun L, Gil-Raga M, Cano-Cano J, Calderon C. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors. Curr Oncol. 2023;30(10):9205–9216. doi: https://doi.org/10.3390/curroncol30100665

Article  PubMed  PubMed Central  Google Scholar 

Pourmir I, Nebbache R, Champiat S, Lambotte O; Cancer Immunotherapy Adverse Events Working Group. Reporting and analysis of immunotherapy trials adverse events: What is going wrong, how to do better? Ann Oncol. 2024;35(6):569–570. doi:https://doi.org/10.1016/j.annonc.2024.03.006

Article  PubMed  CAS  Google Scholar 

Joseph M Unger, Riha Vaidya, Dawn L Hershman, Lori M Minasian, Mark E Fleury, Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation, JNCI: Journal of the National Cancer Institute, Volume 111, Issue 3, March 2019, Pages 245–255, https://doi.org/10.1093/jnci/djy221

Karen M. Winkfield et al. Addressing Financial Barriers to Patient participation in Clinical Trials: ASCO Policy Statement. JCO 36, 3331–3339(2018). DOI:https://doi.org/10.1200/JCO.18.01132

Tsai JH, Yin SC, Chen CF. Withdrawal reasons in oncology clinical trials: A systematic review. Asian Pac J Oncol Nurs. 2021;8(3):198–204. doi:https://doi.org/10.1016/j.apjon.2021.03.001

Article  Google Scholar 

Daly B, Brawley OW, Gospodarowicz MK, et al. Remote monitoring and data collection for decentralized clinical trials. JAMA Netw Open. 2024;7(4):e246228. doi:https://doi.org/10.1001/jamanetworkopen.2024.6228

Article  PubMed  PubMed Central  Google Scholar 

Sinha SD, Chary Sriramadasu S, Raphael R, et al. Decentralisation in clinical trials and patient centricity: Benefits and challenges. Pharm Med. 2024;38:109–120. doi:https://doi.org/10.1007/s40290-024-00518-x

Article  Google Scholar 

Chow R, Drkulec H, Im JHB, et al. The use of wearable devices in oncology patients: A systematic review. Oncologist. 2024;29(4):e419–e430. doi:https://doi.org/10.1093/oncolo/oyad305

Article  PubMed  Google Scholar 

Izmailova ES, Wagner JA, Perakslis ED. Wearable devices in clinical trials: Hype and hypothesis. Clin Pharmacol Ther. 2018;104(1):42–52. doi:https://doi.org/10.1002/cpt.966

Article  PubMed  PubMed Central  Google Scholar 

Artusi CA, Imbalzano G, Sturchio A, et al. Implementation of mobile health technologies in clinical trials of movement disorders: Underutilized potential. Neurotherapeutics. 2020;17:1736–1746. doi:https://doi.org/10.1007/s13311-020-00901-x

Article  PubMed  PubMed Central  Google Scholar 

Kessel KA, Vogel MM, Kessel C, et al. Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth. 2017;5(6):e81. doi:https://doi.org/10.2196/mhealth.7689

Article  PubMed  PubMed Central  Google Scholar 

Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi:https://doi.org/10.1200/JCO.2015.63.0830

Article  PubMed  CAS  Google Scholar 

Coppola C, Rienzo A, Piscopo G, et al. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Cancer Treat Rev. 2018;63:135–143. doi:https://doi.org/10.1016/j.ctrv.2017.11.009

Article  PubMed  CAS  Google Scholar 

Koltowski L, Balsam P, Glowczynska R, Rokicki JK, Peller M, Maksym J, Blicharz L, Maciejewski K, Niedziela M, Opolski G, Grabowski M. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Cardiol J. 2021;28(4):543–548. doi: https://doi.org/10.5603/CJ.a2019.0001.

Article  PubMed  PubMed Central  Google Scholar 

Chung EH, Guise KD. QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation. J Electrocardiol. 2015 Jan-Feb;48(1):8–9. doi: https://doi.org/10.1016/j.jelectrocard.2014.10.005. Epub 2014 Nov 19. PMID: 25453194.

Article  PubMed